Overview

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

Status:
Completed

Trial end date:
2016-10-17

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of pioglitazone 30 mg on glycemic control when used in participants with inadequately controlled type 2 diabetes mellitus treated with stable combinations of metformin and sulfonylurea.

Phase:

Phase 4

Details

Lead Sponsor:

Takeda

Treatments:

Metformin
Pioglitazone